Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing reduced-dose total body irradiation with cyclophosphamide, fludarabine, and melphalan as reduced-intensity conditioning in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Fludarabine (Fludarabine)
  • Melphalan (Melphalan)

Snippet

Sponsor: University of Birmingham | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING